Feasibility assessment is a critical step in conducting a successful clinical trial. Selecting the right site can be beneficial for both the sponsor and the clinical site. In addition, it can provide an opportunity for many patients to be enrolled in a study that may change their life. Therefore, the…
According to the FDA website, Real-World Data (RWD) is the data relating to patient health status and/or the delivery of health care, routinely collected from a variety of sources. RWD can come from a number of sources including Electronic Health Records (EHRs), claims and billing activities, product and disease registries, patient-generated data…
The very first step of conducting a clinical trial is to find the right clinical site and Principal Investigator (PI). Sponsors or CROs usually have specific criteria for selecting a site based on the study design and protocol. There are several ways that sponsors find potential clinical sites before conducting…
In traditional trial designs, a single drug is tested in a single disease population in one clinical trial. In contrast to traditional trial designs, master protocols, use a single infrastructure, trial design, and protocol to simultaneously evaluate multiple drugs and/or disease populations in multiple substudies, allowing for efficient and accelerated…
Clinical Research Associates (CRAs) also called clinical monitors or trial monitors are the ones who are responsible to oversee the clinical trials on behalf of the sponsor. They have several responsibilities including but not limited to Source Data Verification (SDV), Source Data Review (SDR), writing reports, scheduling monitoring visits, and…
A Note to File (NTF) is a record that allows the clinical site and the sponsor to document an identified issue or discrepancy during a clinical study. A NTF should include the following items: · The root cause of the discrepancy/issue · The corrective action taken to prevent its recurrence · Explanation of…